BOF
BranchOut Food Inc.
There isn't enough reported data to score BOF yet.
CELH
Celsius Holdings, Inc.
CELH's fundamentals are strong and it looks cheap: trading at 35x earnings, less than half its usual 142x. Analysts expect strong earnings growth, though they disagree widely on how much.
BOF Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Under pressure | |
| Unavailable |
BOF's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
BOF PE Valuation
BOF has no meaningful PE right now: it lost money over the past year.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
BOF Forward outlook
There aren't enough analyst estimates for BOF to show an outlook.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
BOF Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.59 | +$0.04 |
| Q1 2026 | -$0.58 | +$0.10 |
| Q4 2025 | -$0.57 | +$0.26 |
| Q3 2023 | -$2.97 | +$0.04 |
| Q2 2023 | -$3.47 | -$0.78 |
BOF is still losing money, but far less than before: $0.59 per share over the past year, against $4.71 at its worst in late 2022.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over BOF on earnings quality, reporting a profit while its opponent remains loss making.
BOF Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.5M | +35% |
| Q1 2026 | $2.6M | -18% |
| Q4 2025 | $4M | +167% |
| Q3 2025 | $3.2M | +48% |
| Q2 2025 | $3.3M | +142% |
| Q1 2025 | $3.2M | +118% |
| Q4 2024 | $1.5M | +1.8% |
| Q3 2024 | $2.2M | +141% |
BOF has the edge over CELH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -58% | -17 points |
| Q1 2026 | -62% | -41 points |
| Q4 2025 | -48% | +29 points |
| Q3 2025 | -44% | -2.9 points |
| Q2 2025 | -41% | +20 points |
| Q1 2025 | -21% | +49 points |
| Q4 2024 | -76% | +21 points |
| Q3 2024 | -41% | +36 points |
BOF's operating margin was −58% last quarter, down 17 points from the same quarter a year ago.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over BOF on profitability, with a higher operating margin.
BOF Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3M | -$863.5K |
| Q1 2026 | -$2.6M | -$306.4K |
| Q4 2025 | -$2.1M | +$218.9K |
| Q3 2025 | -$1.2M | +$2.2M |
| Q2 2025 | -$2.1M | -$749K |
| Q1 2025 | -$2.3M | -$1.8M |
| Q4 2024 | -$2.3M | -$2M |
| Q3 2024 | -$3.4M | -$2.9M |
BOF has burned cash in almost every quarter: −$9M over the past year, against −$10M the year before.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over BOF on cash generation, producing positive trailing cash flow while its opponent burns cash.
BOF Net Leverage
BOF's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
BOF Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.0 | Oversold |
| Stochastic | 3.5 | Oversold |
BOF's weekly RSI is 29 (oversold) and its Stochastic is 4 (oversold).
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
BOF PE vs Consumer Defensive Sector
BOF has no meaningful PE right now: it lost money over the past year.
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
BOF Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.56 | 31% below |
| 20 week MA | $3.45 | 49% below |
| 50 week MA | $3.53 | 50% below |
| 100 week MA | $2.87 | 38% below |
CELH has stronger trend alignment. BOF is above 0 of 4 weekly averages versus CELH above 2 of 5.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
BOF Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $4.43 | $1.21 | -73% |
| 2024 | $1.21 | $1.65 | +36% |
| 2025 | $1.65 | $3.36 | +104% |
| 2026 YTD | $3.36 | $1.77 | -47% |
BOF's yearly returns have swung widely, from +104% in 2025 to −73% in 2023. It's down 47% so far in 2026.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH has the edge over BOF on returns for 2026, with the stronger performance.